Levonorgestrel butanoate

Phase 2Small molecule

PPremier Research

Levonorgestrel butanoate is one of 27 small molecule programs targeting Contraception. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ContraceptionNot yet recruiting

ContraceptionPhase 2

Not yet recruiting

Competition

Competitive Landscape

37 competitors in Contraception

#DrugCompanyPhaseTrials

Jadelle

IItalian Network for Tumor Biotherapy Foundation

Approved

12 2

Tivicay

GSK

Approved

1 3

Estrace

Cytotec

Implanon

3 6

Prometrium

Advil

Xylocaine

Ultram

Imdur

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2029

Phase 2Not yet recruiting

Contraception

NCT07222228

Clinical

Trials by Indication[1]

Contraception3 trials

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Active, not recruiting·PPremier Research·Phase 1·NCT04143659·136 enrolled

A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception

Completed·PPremier Research·Phase 1·NCT02173808·16 enrolled

A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

Not yet recruiting·PPremier Research·Phase 2·NCT07222228·165 enrolled

Efficacy and Safety1 trial

A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)

Completed·PPremier Research·Phase 1/2·NCT01166412·121 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Levonorgestrel butanoate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Levonorgestrel butanoate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Levonorgestrel butanoate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Premier Research company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: PPremier Research

Levonorgestrel butanoate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2029

Trials by Indication[1]

Contraception3 trials

Efficacy and Safety1 trial

References

Drug Info

Quick Facts

Related News